Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Provided By GlobeNewswire

Last update: Jan 8, 2025

IRVINE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announces the appointment of Dr. Paul Billings as the company’s Consulting Chief Medical Officer. In this part-time role, he will support a range of strategic and clinical goals for Oncocyte.